|
Sign In to gain access to subscriptions and/or personal tools.
|
Spinal Muscular Atrophy Diagnostics
Thomas W. Prior, PhD
Department of Pathology, Ohio State University, Columbus, Ohio, thomas.prior{at}osumc.edu
Spinal muscular atrophy is a common autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron gene (SMN), which exists in 2 nearly identical copies (SMN1 and SMN2). Exon 7 of SMN1 is homozygously absent in about 95% of spinal muscular atrophy patients, whereas the loss of SMN2 does not cause spinal muscular atrophy. Small mutations are found in the other 5% of affected patients, and these mutations cluster in the 3' end of SMN1, a region important for protein oligomerization. SMN1 dosage testing can be used to determine the SMN1 copy number and to detect spinal muscular atrophy carriers and affected compound heterozygotes. Dosage testing is compromised by the presence of 2 SMN1 copies per chromosome, which occurs in about 2% of carriers. Finally, although SMN2 produces less full-length transcript than SMN1, the number of SMN2 copies modulates the phenotype.
Key Words: spinal muscular atrophy • SMN1 gene • gene dosage testing • SMN2 gene
References
- Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet. 1978; 15:409-413.[Abstract/Free Full Text]
- Lefebvre S., Burglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155-165.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pyatt RE, Prior TW A feasibility study for newborn screening of spinal muscular atrophy. Genet Med. 2006;8:428-437.[Web of Science][Medline]
[Order article via Infotrieve]
- McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet. 1997;60:1411-1422.[Web of Science][Medline]
[Order article via Infotrieve]
- Wirth B., Schmidt T., Hahnen, et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications in genetic counseling. Am J Hum Genet. 1997;61:1102-1111.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mailman MD, Hemingway T., Darsey RL, et al. Hybrids monosomal for human chromosome reveals the presence of a spinal muscular atrophy (spinal muscular atrophy) carrier with two SMN1 copies on one chromosome. Hum Genet. 2001;108:109-115.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lorson CL, Androphy EJ An exonic enhancer is required for inclusion of an essential exon in the spinal muscular atrophy-determining gene SMN. Hum Mol Genet. 2000;9:259-265.[Abstract/Free Full Text]
- Lorson CL, Hahnen E., Androphy EJ, et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96:6307-6311.[Abstract/Free Full Text]
- Campbell L., Potter A., Ignatius J., et al. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet. 1997; 61:40-50.[Web of Science][Medline]
[Order article via Infotrieve]
- Wirth B., Herz M., Wetter A., et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;64:1340-1356.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Feldkotter M., Schwarzer V., Virth R., Wienker TF, Wirth B. Quantitative analysis of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358-368.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenou type by SMN2. Genet Med. 2002;4:20-26.[Web of Science][Medline]
[Order article via Infotrieve]
- Prior TW, Swoboda KJ, Scott HD, et al. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype. Am J Med Genet. 2004;130A:307-310.
- Burghes Ahm. When is a deletion not a deletion? When it is converted. Am J Hum Genet. 1997;61:9-15.[Web of Science][Medline]
[Order article via Infotrieve]
- Hsieh-Li, Chang JG, Jong YJ, et al. A mouse model for spinal muscular atrophy. Nat Genet. 2000;26:66-70.
- Monani UR, Coovert DD, Burghes Ahm. Animal models of spinal muscular atrophy. Hum Mol Genet. 2000;9:2451-2457.[Abstract/Free Full Text]
- Hoffman Y., Lorson CL, Stamm S., et al. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full length SMN expression to survival motor neuron 2 (SMN2). Proc Nat Acad Sci USA. 2000;97:9618-9623.[Abstract/Free Full Text]
- Parsons DW, McAndrew PE, Iannaccone ST, et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect and modification of spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet. 1998;63:1712-1723.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Child Neurology, Vol. 22, No. 8,
952-956 (2007)
DOI: 10.1177/0883073807305668
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
R. A. Brumback
Child Neurologists Should Be Interested In Brain Tumors!
J Child Neurol,
November 1, 2009;
24(11):
1338 - 1340.
[PDF]
|
|
|
|
|
|
|
E. Workman, L. Saieva, T. L. Carrel, T. O. Crawford, D. Liu, C. Lutz, C. E. Beattie, L. Pellizzoni, and A. H.M. Burghes
A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice
Hum. Mol. Genet.,
June 15, 2009;
18(12):
2215 - 2229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
